Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Association between Gross National Income per capita and COVID-19 vaccination coverage: a global ecological study.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: BioMed Central Country of Publication: England NLM ID: 100968562 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2458 (Electronic) Linking ISSN: 14712458 NLM ISO Abbreviation: BMC Public Health Subsets: MEDLINE
    • Publication Information:
      Original Publication: London : BioMed Central, [2001-
    • Subject Terms:
      COVID-19*/epidemiology ; COVID-19*/prevention & control ; Vaccines*; Humans ; COVID-19 Vaccines ; Vaccination Coverage ; Vaccination
    • Abstract:
      Background: Coronavirus 2019 (COVID-19) pandemic has claimed over six million lives and infected more than 650 million people globally. Public health agencies have deployed several strategies, including rolling out vaccination campaigns to curb the pandemic, yet a significant proportion of the global population has not received the COVID-19 vaccine. We assessed differences in COVID-19 vaccination coverage by Gross National Income (GNI) per capita of WHO members (i.e., countries, areas, and territories, n = 192) and by WHO member regions (n = 6).
      Methods: Using an ecological study design, we analyzed publicly available data from the WHO website merged with the World Bank's GNI per capita data. We included a total of 192 WHO members and six WHO regions in the analysis. We utilized negative binomial regression to assess the associations between the GNI per capita and COVID-19 vaccination coverage (cumulative number of persons fully vaccinated and/or received at least one dose of the vaccine per 100 population), and ANOVA test to assess the differences in vaccination coverage per WHO regions.
      Results: Low GNI per capita WHO members had significantly lower full vaccination coverage (aRR 0.30, 95% CI 0.22-0.40) compared to high GNI per capita WHO members. These members were also 66% less likely to receive at least one dose of the vaccine (aRR 0.34, 0.26-0.44) relative to high GNI per capita WHO members. Africa region had a significantly lower fully vaccination coverage (aRR 0.71, 95% CI 0.36-0.54) and received at least one dose of the COVID-19 vaccine (aRR 0.78, 95% CI 0.62-0.99) than Europe region. Conversely, the Western Pacific region had significantly higher fully vaccination coverage (aRR 1.40 95% CI 1.12-1.74) and received at least one dose of COVID-19 vaccines (aRR 1.40 95% CI 1.14-1.73) relative to European region.
      Conclusion: WHO members with low GNI per capita and the African region reported significantly lower COVID-19 vaccination coverage than those with high GNI per capita or other regions. Efforts to strengthen and promote COVID-19 vaccination in low-income WHO countries and African region should be scaled up.
      (© 2023. The Author(s).)
    • References:
      Trans R Soc Trop Med Hyg. 2021 May 8;115(5):447-456. (PMID: 33733663)
      J Microbiol Biotechnol. 2020 Mar 28;30(3):313-324. (PMID: 32238757)
      Bull World Health Organ. 2021 Jun 1;99(6):406-406A. (PMID: 34108746)
      Vaccines (Basel). 2021 May 17;9(5):. (PMID: 34067682)
      SSM Popul Health. 2021 Aug 24;15:100902. (PMID: 34458549)
      MMWR Morb Mortal Wkly Rep. 2021 Sep 17;70(37):1284-1290. (PMID: 34529637)
      Sci Rep. 2022 Aug 2;12(1):13293. (PMID: 35918372)
      Global Health. 2022 Feb 22;18(1):23. (PMID: 35193616)
      Vaccine. 2021 Jun 2;39(24):3250-3258. (PMID: 33966909)
      Nat Med. 2021 Aug;27(8):1385-1394. (PMID: 34272499)
      Lancet Glob Health. 2016 Oct;4(10):e726-35. (PMID: 27569362)
      NPJ Vaccines. 2021 Apr 14;6(1):54. (PMID: 33854072)
      Health Promot Perspect. 2021 Aug 18;11(3):281-287. (PMID: 34660222)
      BMJ. 2021 Dec 3;375:n3013. (PMID: 34862184)
      Pharm Pract (Granada). 2021 Jan-Mar;19(1):2317. (PMID: 33828623)
      Cell Host Microbe. 2021 Jul 14;29(7):1036-1039. (PMID: 34265241)
      Eur Phys J Plus. 2022;137(1):100. (PMID: 35036269)
      Vaccine. 2015 Aug 14;33(34):4180-90. (PMID: 25896377)
      Drugs Context. 2021 Feb 16;10:. (PMID: 33643421)
      Expert Rev Clin Pharmacol. 2021 May;14(5):601-621. (PMID: 33705239)
      Nat Hum Behav. 2021 Jul;5(7):947-953. (PMID: 33972767)
      Transp Res E Logist Transp Rev. 2021 Dec;156:102542. (PMID: 34815731)
      Sci Rep. 2022 Jan 28;12(1):1554. (PMID: 35091640)
      Health Policy. 2021 May;125(5):553-567. (PMID: 33820678)
      Vaccine. 2021 Sep 24;39(40):5762-5768. (PMID: 34481700)
      Viruses. 2020 Mar 27;12(4):. (PMID: 32230900)
      Immunity. 2021 Jul 13;54(7):1353-1362. (PMID: 34260880)
    • Contributed Indexing:
      Keywords: COVID-19; Coronavirus; Low-income; SARS-CoV-2; Vaccination; Vaccine equity; Vaccines
    • Accession Number:
      0 (COVID-19 Vaccines)
      0 (Vaccines)
    • Publication Date:
      Date Created: 20231204 Date Completed: 20231206 Latest Revision: 20240116
    • Publication Date:
      20240117
    • Accession Number:
      PMC10696801
    • Accession Number:
      10.1186/s12889-023-17241-y
    • Accession Number:
      38049821